Active Runners: Dynavax Technologies Corp. (NASDAQ:DVAX) and Hertz Global Holdings Inc (NYSE:HTZ)

Stamford, CT -- (SBWIRE) -- 02/25/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Dynavax Technologies Corp. (NASDAQ:DVAX) shares plunged by over a third following the firm reported that the Food and Drug Administration would not accept its hepatitis B vaccine Heplisav except Dynavax gives more information saying the drug is safe.Dynavax reported that the FDA is worried regarding the possibility of "rare autoimmune events" in patients. The firm has demanded the FDA to accept Heplisav, its most progressive drug, in patients aged 18 to 70, but the FDA favors a narrower marketing accepting. The agency also needs more information regarding the manufacturing and quality of Heplisav.

What does Dynavax chief says about the move? Find out here

The Berkley, Calif., firm reported that it predicts to meet with the FDA within six weeks. Dynavax reported that it does not know how long it would take to content the agency's doubts, but stated it would be willing to discuss a more limited acceptance for Heplisav.

Hertz Global Holdings Inc (NYSE:HTZ) announced a quarterly loss because of costs associated to its takeover of Dollar Thrifty, but revised profit topped experts’ predictions and the car rental firm estimated robust results for 2013 on superior pricing.Hertz estimated revised earnings of $1.82 to $1.92 a share for 2013 on sales of $10.85 billion to $10.95 billion.

How Hertz Global Holdings, Inc.(NYSE:HTZ) investors responded to such figures? Find in this report

Hertz Global Holdings, Inc.(NYSE:HTZ) investors were still happy over such results and its shares were moving up 6.78% on Monday trading session.

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.